APOLLOHOSP

March 31 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS -APOLLO HEALTHCO BUYS 100% OF APOLLO CONSUMER PRODUCTS FOR 900,000 RUPEES

Source text: ID:nBSE4D8ydp

Further company coverage: APLH.NS

(([email protected];))

Corrects paragraph 4 in March 24 story to say Novo Holdings, not Novo Nordisk

By Vibhuti Sharma and Rishika Sadam

BENGALURU, March 24 (Reuters) - India's Manipal Health Enterprises filed for an up to $1.17 billion initial public offering on Tuesday, betting on rising demand for speciality care even as the domestic equities market faces volatility amid fragile global sentiment.

The initial public offering comprises a fresh issue to raise $852.2 million and an offer for sale of about 43.2 million shares by existing investors such as Singapore's Temasek, U.S. investment firm TPG TPG.O, Manipal Education and Novo Holdings, according to its draft prospectus.

Existing investors plan to sell up to 30 billion rupees ($319.58 million) worth of shares, according to two sources familiar with the matter. They did not want to be named because they were not authorised to speak to the media.

Demand for specialised healthcare has surged in the world's most populous country and is a key driver of growth, analysts say, a trend that is increasingly attracting private and foreign investment from firms such as Blackstone BX.N, Novo Holdings and KKR KKR.N.

India remains an undersupplied healthcare market, with strong tailwinds from rising insurance penetration, industry consolidation favouring larger players and higher per capita incomes driving demand for quality care, said Sanjay Singh, head of investment banking at InCred Capital, adding the IPO is likely to see strong interest from both institutional and retail investors.

Manipal's listed rival, Apollo Hospitals APLH.NS said revenue from complex care such as cardiology, oncology, and neurology rose 22.6% in the December 2025 quarter, highlighting growing demand for advanced medical care.

Manipal's IPO plans come amid a sharp slump in India's equities market, with global risk-off sentiment, tightening liquidity and sustained foreign outflows weighing.

Foreign investors have withdrawn more than $11.65 billion from Indian stocks so far in 2026, including more than $10.17 billion in March alone, according to depository data.

MANIPAL'S LAY OF THE LAND

As of September 30, Manipal had about 12,367 operational beds, while Apollo, valued at roughly $10.88 billion, has nearly 10,000 and targets 13,000 beds by fiscal 2030.

For the six months to September 2025, Manipal Health posted a consolidated net profit of 5.61 billion rupees and revenue of 47.13 billion rupees.

The company plans to use IPO proceeds to repay debt and to fund its acquisition of Sahyadri Hospitals, which it bought for $700 million.

($1 = 93.8725 Indian rupees)

(Reporting by Urvi Dugar in Bengaluru, writing by Chandini Monnappa; Editing by Janane Venkatraman and Thomas Derpinghaus)

(([email protected]; +91 9558725583;))

March 23 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS - SHAREHOLDING IN AHLL INCREASES TO 99.42%

Source text: ID:nNSE1Txnds

Further company coverage: APLH.NS

(([email protected];))

Feb 10 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS Q3 CONSOL NET PROFIT 5.02 BILLION RUPEES; IBES EST. 4.82 BILLION RUPEES

• APOLLO HOSPITALS Q3 CONSOL REVENUE FROM OPERATIONS 64.77 BILLION RUPEES; IBES EST. 63.29 BILLION RUPEES

Further company coverage: APLH.NS

(([email protected];))

Jan 20 (Reuters) -

• INDIA COMPETITION COMMISSION: APPROVES ACQUISITION OF ADDITIONAL 30.58% STAKE IN APOLLO HEALTH AND LIFESTYLE BY APOLLO HOSPITALS ENTERPRISE

Further company coverage: APLH.NS

(([email protected];))

Nov 24 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS - OPENS 400-BED FACILITY IN PUNE

Source text: ID:nPre7SYCra

Further company coverage: APLH.NS

(([email protected];;))

Sept 12 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS - TO SET UP COMPREHENSIVE ONCOLOGY FACILITY AT GURUGRAM AT AN INVESTMENT OF 5730 MILLION RUPEES

• APOLLO HOSPITALS - TO ACQUIRE 31% STAKE HELD BY INTERNATIONAL FINANCE CORPORATION IN APOLLO HEALTH & LIFESTYLE

Source text: [ID:]

Further company coverage: APLH.NS

(([email protected];))

Aug 22 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• PROMOTER GROUP, REPRESENTED BY SUNEETA REDDY, SOLD 1.3% STAKE VIA BLOCK DEAL

• SALE PROCEEDS TO BE USED TO REDUCE PROMOTER GROUP DEBT

• PROMOTER GROUP'S SHAREHOLDING REDUCED TO 28% FROM 29.3%

• PROMOTER GROUP HAS NO PLANS FOR FURTHER STAKE REDUCTION

Source text: ID:nnAZN4EHRSU

Further company coverage: APLH.NS

(([email protected];;))

June 30 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• ANNOUNCES RE-ORGANISATION, ENABLING DIRECT LISTING OF ITS OMNI CHANNEL PHARMACY AND DIGITAL HEALTH BUSINESS

• AHEL SHAREHOLDERS TO HAVE DIRECT SHAREHOLDING IN A COMBINED ENTITY

• FOR EVERY 100 SHARES OF AHEL,AHEL SHAREHOLDERS WILL RECEIVE 195.2 SHARES OF NEW ENTITY

• LISTING OF ENTITY EXPECTED IN 18-21 MONTHS

• OMNI CHANNEL PHARMACY AND DIGITAL HEALTH BUSINESS PLANS TO ACHIEVE 250 BILLION RUPEES REVENUE BY FY27, 7% EBITDA MARGIN

• AHEL WILL RETAIN 15% STAKE IN NEWCO

Source text: ID:nBSE20sh82

Further company coverage: APLH.NS

(([email protected];;))

June 23 (Reuters) - Mumbai International Airport Ltd, a subsidiary of Adani Airport Holdings, has secured a $750 million investment from a group led by affiliates of Apollo-managed funds APO.N and other long-term backers, the U.S. private capital group said on Monday.

The four-year unsecured notes will be used to refinance existing debt, with an option to raise an additional $250 million, Apollo said in a statement.

Adani Airports Holdings, the airport division of Adani Enterprises ADEL.NS, secured a $750 million investment earlier this month from a consortium of international banks.

The unit is expected to be spun off and listed by March 2027, according to a Bloomberg report from June.

Adani Airport Holdings currently operates eight airports across India and also oversees the Navi Mumbai International Airport, a strategically located project on the outskirts of Mumbai set become operational soon.

Adani Airport Holdings and Adani Enterprises did not immediately respond to requests for comment outside of business hours.

(Reporting by Chandni Shah in Bengaluru; Editing by Sherry Jacob-Phillips)

(([email protected];))

March 4 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• PLANS TO COMMISSION COMPREHENSIVE ONCOLOGY CENTRE AT COST OF 2.5 BILLION RUPEES

Source text: ID:nNSE5W2Sw6

Further company coverage: APLH.NS

(([email protected];;))

By Bhanvi Satija, Kashish Tandon and Rishika Sadam

HYDERABAD Feb 27 (Reuters) - India should take a page from the playbook of countries such as China and Australia if it wants a larger share of the global clinical trials market, healthcare experts said at an industry conference.

As of 2022, India held an 8% share in global clinical trials - which evaluate the safety and effectiveness of new treatments - compared to China's 29%, the U.S.'s 25%, and 38% for the rest of the world, data from consultancy PwC showed.

"There's a lot to learn from what other countries have done to make them clinical trial destinations," BCG India partner Smruthi Suryaprakash said, pointing out that China saw an increase in innovation after easing regulations, while Australia has benefited from offering significant tax incentives.

India's clinical trials research market is rapidly expanding, supported by a diverse patient base, cost-effective solutions, and a growing hospital network, according to U.S.-based GrandView Research, which forecasts revenues exceeding $2 billion by 2030.

"India will be able to capture the clinical trial (market) if we can really work on the speed. I think speed is what is really important to sponsors, either with regulator or being able to recruit patients faster," Suryaprakash added.

Suryaprakash, along with other experts, was speaking as part of a panel at the BioAsia conference in the southern Indian state of Telangana.

Rajeev Raghuvanshi, who heads India's drug regulator, said it was working to make the regulatory process more streamlined for global trials in India, based on feedback from stakeholders.

"We have aligned things every year on average for the last three years," the drugs controller general of India said.

The agency which revamped its trial rules in 2019, had approved about 160 trials in the last three years, he added.

RECRUITING THE RIGHT PATIENTS

Allowing sponsors to raise awareness among patients, such as through advertisements of ongoing studies, would also help India advance as a recruitment site, the experts said.

Advertising studies for experimental treatments could be helpful, especially for patients with rare diseases without many treatment options. It is a common practice in countries such as the U.S. and the U.K.

"You're not able to recruit into the trial because they (patients) do not know that it exists," said Padmaja Lokireddy, an oncologist at Apollo Hospitals APLH.NS.

That needs to change, experts said.

Some other experts highlighted challenges related to preparing a clinical trial site, ensuring it meets global safety standards and recruiting the right patients.

(Reporting by Bhanvi Satija, Kashish Tandon and Rishika Sadam in Hyderabad; Editing by Manas Mishra, Dhanya Skariachan and Tasim Zahid)

(([email protected]; Outside U.S. +91 9873062788;))

BENGALURU, Feb 10 (Reuters) - Diary of India economic, corporate events on Feb 10

ECONOMIC, CORPORATE .BSE500 EVENTS:

NTS - 'No time scheduled'

(Compiled by Bengaluru Newsroom)

(([email protected]))

Dec 24 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS ENTERPRISE - HEALTHCO TO ACQUIRE SOFTWARE BUSINESS FROM SEARCHLIGHT HEALTH

• APOLLO HOSPITALS ENTERPRISE - DEAL VALUED AT 675 MILLION RUPEES

Source text: ID:nNSE4g7SLs

Further company coverage: APLH.NS

(([email protected];))

Nov 29 (Reuters) - India's Aster DM Healthcare ATRD.NS will merge with Blackstone-backed hospitals operator Quality Care India, the companies said on Friday, bringing Aster closer to its larger rivals Apollo Hospitals and Manipal Hospitals.

This is Aster's first major deal since selling its Gulf business. The company will get access to Quality's 5,500 beds, taking the merged entity's total bed count to more than 10,000.

The acquisition will bring Aster's domestic capacity close to that of market leader Apollo Hospitals APLH.NS and the privately-held Manipal Hospitals, making it one of the top three hospital chains in the country.

The merged entity, which will be called Aster DM Quality Care, plans to add another 3,500 beds by fiscal year 2027, funded through internal accruals. Earlier this year, Aster laid out plans to spend up to $108 million to boost its domestic capacity across the 19 hospitals it runs in India.

The combined entity will be jointly controlled by Aster's top shareholders and Blackstone, with respective holdings of 24% and 30.7%. The company did not specify the size of the deal.

Post the merger, Aster's shareholders will hold a 57.3% stake in the combined firm, with Quality Care - which operates CARE Hospitals, KIMS Health and Evercare hospital chains in India - owning the rest.

Azad Moopen, Aster's founder and managing director, will continue in his role and oversee the merged entity, while Varun Khanna, MD of Quality Care, will helm the merged entity as the CEO, the two companies said.

(Reporting by Kashish Tandon in Bengaluru; Editing by Janane Venkatraman)

(([email protected]; 8800437922;))

-- Source link: https://tinyurl.com/253e3z8p

-- Note: Reuters has not verified this story and does not vouch for its accuracy

((Bengaluru newsroom, [email protected]))

Nov 6 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• Q2 CONSOL NET PROFIT 3.79 BILLION RUPEES; IBES EST. 3.64 BILLION RUPEES

• Q2 CONSOL REV FROM OPS 55.89 BLN RUPEES; IBES EST. 55.13 BLN RUPEES

Source text: [ID:]

Further company coverage: APLH.NS

(([email protected];;))

Nov 1 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS - PLANS TO ADD OVER 3512 CAPACITY BEDS OVER NEXT 4 YRS IN 11 LOCATIONS IN INDIA

• APOLLO HOSPITALS - TOTAL ESTIMATED PROJECT COST FOR THE 11 PROJECTS IS 61 BILLION RUPEES

Source text: ID:nNSE51p1hS

Further company coverage: APLH.NS

(([email protected];;))

Aug 21 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS - INDIA COMPETITION REGULATOR CCI APPROVED ACQUISITION BY ADVENT IN APOLLO HEALTHCO

• APOLLO HOSPITALS - CCI ALSO APPROVED ACQUISITION BY CO IN KEIMED PVT LTD

• APOLLO HOSPITALS - CCI ALSO APPROVED MERGER OF KEIMED INTO AHL

Source text for Eikon: ID:nNSE7fRB0M

Further company coverage: APLH.NS

(([email protected];))

Aug 13 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS ENTERPRISE Q1 CONSOL NET PROFIT 3.05 BILLION RUPEES

• APOLLO HOSPITALS ENTERPRISE Q1 CONSOL REVENUE FROM OPERATIONS 50.86 BILLION RUPEES

Further company coverage: APLH.NS

(([email protected];))

May 30 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS ENTERPRISE Q4 CONSOL NET PROFIT 2.54 BILLION RUPEES; LSEG IBES PROFIT EST. 2.65 BILLION RUPEES

• APOLLO HOSPITALS ENTERPRISE Q4 CONSOL REVENUE FROM OPERATIONS 49.44 BILLION RUPEES; LSEG IBES EST. 49.43 BILLION RUPEES

• APOLLO HOSPITALS ENTERPRISE LTD - DIVIDEND OF 10 RUPEES PER SHARE

• APOLLO HOSPITALS ENTERPRISE YEAR AGO Q4 CONSOL PROFIT 1.45 BILLION RUPEES, REVENUE 43.02 BILLION RUPEES

• APOLLO HOSPITALS ENTERPRISE LTD - REAPPOINTMENT OF PRATHAP C REDDY AS AN EXECUTIVE CHAIRMAN

Source text for Eikon: [ID:]

Further company coverage: APLH.NS

(([email protected];))

Adds source

-- Source link: https://bloom.bg/4biPfkw

-- Note: Reuters has not verified this story and does not vouch for its accuracy

((Bengaluru newsroom, [email protected]))

April 29 (Reuters) - Shares of India's Apollo Hospitals Enterprise APLH.NS fell as much as 8.4% on Monday, after the hospital chain sold a stake in its digital unit in a deal that brokerages said undervalued the subsidiary.

The stock trimmed some losses and was last down 4.5%, set for its worst day since June 2, 2022. The stock was the second biggest percentage loser on India's bluechip Nifty 50 index .NSEI, which was last up 0.65%.

Apollo Hospitals, the country's largest hospital chain by bed capacity, said on Friday that Advent International will invest nearly $297 million in its digital unit Apollo HealthCo. The hospital chain will also merge its online pharmacy business with pharmacy distributor Keimed. Advent will own a 12.1% stake in the merged entity.

The valuation of Apollo HealthCo from the investment is smaller-than-expected, brokerages Nuvama Institutional Equities, Jefferies, CLSA and Prabhudas Lilladher said.

"HealthCo's $1.7 billion valuation came as a negative surprise since $2.7 billion was expected, and management also accepted that (Apollo's pharmacy business) 24/7 did not receive the valuation it deserved," analysts at Nuvama said in a note.

Apollo HealthCo, which includes offline, online pharmacies and a tele-medicine business, has been pressuring the hospital operator's bottom line, hurt by its cash-guzzling business Apollo 24/7.

The fundraise and the merger with Keimed are positive, as they will enable Apollo HealthCo to expand as an integrated pharmacy player while not having to worry about cash burn, the analysts said.

Nuvama, Jefferies, and Prabhudas Lilladher maintained their "buy" rating on Apollo Hospitals' stock while CLSA kept its "outperform" rating.

The stock's rating on an average is "buy", per LSEG data, with the average price target at 6,953.5 rupees, 14% higher than its current price of 5,979 rupees.

(Reporting by Rishika Sadam and Varun Hebbalalu; Editing by Mrigank Dhaniwala)

(([email protected];))

April 26 (Reuters) - Apollo Hospitals Enterprise Ltd APLH.NS:

• APOLLO HOSPITALS ENTERPRISE - APPROVAL FOR PRIMARY INVESTMENT OF 24.75 BILLION RUPEES BY RASMELI INTO APOLLO HEALTHCO

• APOLLO HOSPITALS ENTERPRISE LTD- APOLLO 2417 TO RAISE 24.75 BILLION RUPEES FROM ADVENT INTERNATIONAL

• APOLLO HOSPITALS ENTERPRISE LTD- TO MERGE KEIMED WITH APOLLO 2417

• APOLLO HOSPITALS ENTERPRISE LTD- ADVENT SHALL INVEST IN COMPULSORY CONVERTIBLE INSTRUMENTS OVER 2 TRANCHES TO SECURE 12.1 % STAKE IN MERGED ENTITY

• APOLLO HOSPITALS ENTERPRISE LTD- ADVENT VALUING COMBINED ENTITY AT AN ENTERPRISE VALUE OF 224.81 BILLION RUPEES

• APOLLO HOSPITALS ENTERPRISE LTD- KEIMED SHAREHOLDERS WOULD HOLD A MAXIMUM OF 25.7% STAKE IN COMBINED ENTITY

• APOLLO HOSPITALS ENTERPRISE LTD- AHEL WOULD CONTINUE TO REMAIN LARGEST CONTROLLING SHAREHOLDER WITH AT LEAST 59.2% STAKE

• APOLLO HOSPITALS ENTERPRISE LTD- MERGER WITH KEIMED IS ESTIMATED TO BE EPS ACCRETIVE FROM YEAR 1

Source text for Eikon: ID:nNSEdL5rX

Further company coverage: APLH.NS

(([email protected];))

Added business expansion plan, background

BENGALURU, March 20 (Reuters) - Indian hospital chain Aster DM Healthcare ATRD.NS said on Wednesday it plans to spend up to 9 billion rupees (about $108 million) to expand domestically as it nears the completion of selling its Gulf business.

Aster said it aims to be among the top three hospital chains in India and expects to add about 1,500 beds by fiscal 2027 to the 4,857 beds it currently has across 18 hospitals in the country.

In contrast, Apollo Hospitals APLH.NS, India's largest private hospital chain, has more than 10,000 beds across over 70 hospitals, while Manipal Health has 33 hospitals with more than 9,500 beds.

Aster said it would expand its presence both by building new hospitals and by boosting the capacity at existing centres, it said.

Last November, Aster agreed to sell a majority stake in its Gulf business, which accounts for about 75% of its overall revenue, to a consortium led by private equity firm Fajr Capital.

After a proxy advisory firm threatened to scuttle the deal, Aster said it would distribute about 70%-80% of the $903 million net proceeds from the sale to shareholders.

The Fajr Capital-led consortium got local anti-trust clearance and approvals from key partners for the deal, Aster said, without specifying when it expects the deal to close.

While India accounted for only a quarter of Aster's total revenue in the third quarter, the growth in the region outpaced the revenue growth in the Gulf.

Since announcing the deal in late November, Aster's shares have jumped nearly 32% through their close on Wednesday.

($1 = 83.1430 Indian rupees)

(Reporting by Ashish Chandra in Bengaluru; Editing by Dhanya Ann Thoppil)

(([email protected]; +91 7982114624;))